Genome-wide search for loss of heterozygosity shows extensive genetic diversity of human breast carcinomas

Cancer Research

Volumn 57, Issue 24, 1997, Pages 5469-5474

  Kerangueven, Fabienne ^a   Noguchi, Tetsuro ^a   Coulier, François ^b   Allione, Florence ^a   Wargniez, Véronique ^a   Simony Lafontaine, Joelle ^d   Longy, Michel ^c   Jacquemier, Jocelyne ^a   Sobol, Hagay ^a   Eisinger, François ^a   Birnbaum, Daniel ^a,b  

^a INSTITUT PAOLI CALMETTES   (France)

^b INSERM   (France)

^c INSTITUT BERGONIÉ   (France)

^d CENTRE VAL D AURELLE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; ARTICLE; BIODIVERSITY; BREAST CARCINOMA; CELL PROLIFERATION; FEMALE; GENE DELETION; HETEROZYGOSITY; HETEROZYGOSITY LOSS; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MITOSIS INDEX; PHYLOGENY; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

ALLELES; BREAST NEOPLASMS; FEMALE; GENOME, HUMAN; HUMANS; LOSS OF HETEROZYGOSITY; MIDDLE AGED; PHYLOGENY; VARIATION (GENETICS);

EID: 15144340686     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Devilee, P., and Cornelisse, C. Somatic genetic changes in human breast cancer. Biochim. Biophys. Acta, 1198: 113-130, 1994.
2. Bièche, I., and Lidereau, R. Genetic alterations in breast cancer. Genes Chromosomes Cancer, 14: 227-251, 1995.
3. Negrini, M., Monaco, C., Vorechovsky, I., Ohta, M., Druck, T., Baffa, R., Huebner, K., and Croce, C. The FHIT gene at 3pl4.2 is abnormal in breast carcinomas. Cancer Res., 56: 3173-3179, 1996.
4. Li, J., Yen, C., Liaw, D., Podsypanina, K., Bose, S., Wang, S., Puc, J., Milaresis, C., Rodgers, L., McCombie, R., Bigner, S., Giovanella, B., Ittman, M., Tycko, B., Bibshoosh, H., Wigler, M., and Parsons, R. PTEN. a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science (Washington DC), 275: 1943-1947, 1997.
5. Li, L., Li, X., Francke, U., and Cohen, S. The TSG101 tumor susceptibility gene is located in chromosome 11 band p15 and is mutated in human breast cancer. Cell, 88: 143-154, 1997.
6. Steck, P., Pershouse, M., Jasser, S., Yung, A., Lin, H., Ligon, A., Langford, L., Baumgard, M., Mattier, T., Davis, T., Frye, C., Hu, R., Swedlund, B., Teng, D., and Tavtigian, S. Identification of a candidate tumour suppressor gene, MMAC1 at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat. Genet., 15: 356-362, 1997.
7. Gyapay, G., Morissette, J., Vignal, A., Dib, C., Fizames, C., Millasseau, P., Marc, S., Bernardi, G., Lathrop, M., and Weissenbach, J. The 1992-94 Généthon human genetic linkage map. Nat. Genet., 7: 246-339, 1994.
8. Dib, C., Fauré. S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Hazan, J., Seboun, E., Lathrop, M., Gyapay, G., Morissette, J., and Weissenbach, J. A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature (Lond.), 380: 152-154, 1996.
9. Matise, T. C., Perlin, M., and Chakravarti, A. Automated construction of genetic linkage maps using an expert system (Multimap): a human genome linkage map. Nat. Genet., 6: 384-390, 1994.
10. Tomfordhe, J., Wood, S., Schertzer, M., Wagner, M., Wells, D., Parrish, J., Sadler, L., Blanton, S., Daiger, S., Wang, Z., Wilkie, P., and Weber, J. Human chromosome 8 linkage map based on short tandem repeat polymorphisms: effect of genotyping errors. Genomics. 14: 144-152, 1992.
11. Rogaev, E., Rogaeva, E., Lukiw, W., Vaula, G., Liang, Y., Hancock, R., Crapper McLachlan, D., and St. George-Hyslop, P. An informative microsatellite repeat polymorphism in the human neurofilament light polypeptide (NEFL) gene. Hum. Mol. Genet., 1: 781, 1992.
12. Kerangueven, F., Allione, F., Noguchi, T., Adélaïde, J., Sobol, H., Jacquemier, J., and Birnbaum, D. Patterns of loss of heterozygosity at loci from chromosome arm 13q suggest a possible involvement of BRCA2 in sporadic breast tumors. Genes Chromosomes Cancer, 13: 271-274, 1995.
13. Kerangueven, F., Eisinger, F., Noguchi, T., Allione, F., Wargniez, V., Eng, C., Padberg, G., Theillet, C., Jacquemier, J., Longy, M., Sobol, H., and Birnbaum, D. Loss of heterozygosity in human breast carcinomas in the ataxia telangiectasia, Cowden disease and BRCAI gene regions. Oncogene, 14: 339-347, 1997.
14. Dorion-Bonnet, F., Mautalen, S., and Longy, M. Allelic imbalance study of 16q in human primary breast carcinomas using microsatellite markers. Genes Chromosomes Cancer, 14: 171-181, 1995.
15. Driouch, K., Dorion-Bonnet, F., Brifford, M., Champème, M. H., Longy, M., and Lidereau, R. Loss of heterozygosity on chromosome arm 16q in breast cancer metastases. Genes Chromosomes Cancer, 19: 185-191, 1997.
16. Kirchweger, R., Zeillinger, R., Schneeberger, C., Speiser, P., Louason, G., and Theillet, C. Patterns of allele losses suggest the existence of five distinct regions of LOH on chromosome 17 in breast cancer. Int. J. Cancer, 56: 193-199, 1994.
17. Noviello, C., Courjal, F., and Theillet, C. Loss of heterozygosity on the long arm of chromosome 6 in breast cancer: possibly four regions of deletion. Clin. Cancer Res., 2: 1601-1606, 1996.
18. Devilee, P., Hermans, J., Eyfjörd, J., Borresen, A. L., Lidereau, R., Sobol, H., Borg, A., Cleton-Jansen, A. M., Olah, E., Cohen, B. B., Scherneck, S., Hamann, U., Peterlin, B., Caligo, M., Bignon, Y. J., Maugard, C., and the Breast Cancer Somatic Genetics Consortium. Loss of heterozygosity at 7q31 in breast cancer: results from an international collaborative study. Genes Chromosomes Cancer, 18: 193-199, 1997.
19. Felsenstein, J. PHYLIP. Phylogeny Inference Package (version 3.2). Cladistics, 5: 164-166, 1989.
20. Felsenstein, J. Confidence limits on phylogenies: an approach using the bootstrap. Evolution, 39: 783-791, 1985.
21. Higgins, D. G., Bleasby, A. J., and Fuchs, R. Clustal V: improved software for multiple sequence alignment. Comput. Appl. Biosci., 8: 189-191, 1991.
22. Hollander, M., and Wolfe, D. The one way out. In: M. Hollander and D. Wolfe (eds.), Non Parametric Statistical Methods, pp. 115-132. New York: John Wiley & Sons, 1973.
23. Agresti, A., Mehta, C., and Patel, N. Exact inference for contingency tables with ordered categories. J. Am. Stat. Assoc., 85: 543-458, 1990.
24. Tsuda, H., Callen, D., Fukutomi, T., Nakamura, Y., and Hirohashi, S. Allele loss on chromosome 16q24.2-qter occurs frequently in breast cancers irrespectively of differences in phenotype and extent of spread. Cancer Res., 54: 513-517, 1994.
25. Lakhani, S. R., Collins, N., Stratton, M. R., and Sloane, J. P. Atypical ductal hyperplasia of the breast: clonal proliferation with loss of heterozygosity on chromosomes 16q and 17p. J. Clin. Pathol., 48: 611-615, 1995.
26. Radford, D., Fair, K., Phillips, N., Ritter, J., Steinbrueck, T., Holt, M., and Donis-Keller, H. Allelotyping of ductal carcinoma in situ of the breast: deletion of loci on 8p, 13q, 16q, 17p and 17q. Cancer Res., 55: 3399-3405, 1995.
27. Chen, T., Sahin, A., and Aldaz, M. Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: refining a putative tumor suppressor genes region. Cancer Res., 56: 5605-5609, 1996.
28. Fujii, H., Szumel, R., Marsh, C., Zhou, W., and Gabrielson, E. Genetic progression, histological grade, and allelic loss in ductal carcinoma in situ of the breast. Cancer Res., 56: 5260-5265, 1996.
29. Larsson, C., Byström, C., Skoog, L., Rotstein, S., and Nordenskjöld, M. Genomic alterations in human breast carcinomas. Genes Chromosomes Cancer, 2: 191-197, 1990.
30. Sato, T., Tanigami, A., Yamakawa, K., Akiyama, F., Kasumi, F., Sakamoto, G., and Nakamura, Y. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer. Cancer Res., 50: 7184-7189, 1990.
31. Devilee, P., Van Vliet, M., Van Sloun, P., Kuipers Dijshoorn, N., Hermans, J., Pearson, P., and Cornelisse, C. Allelotype of human breast carcinoma: a second major site for loss of heterozygosity is on chromosome 6q. Oncogene, 6: 1705-1711, 1991.
32. Andersen, T., Gaustad, A., Ottestad, L., Farrants, G., Nesland, J., Tveit, K., and Borresen, A-L. Genetic alterations of the tumour suppressor gene regions 3p, 11p, 13q, 17p, and 17q in human breast carcinomas. Genes Chromosomes Cancer, 4: 113-121, 1992.
33. Carter, S., Negrini, M., Baffa, R., Gillum, D., Rosenberg, A., Schwartz, G., and Croce, C. Loss of heterozygosity at 12q22-q23 in breast cancer. Cancer Res., 54: 6270-6274, 1994,
34. Boige, V., Laurent-Puig, P., Fouchet, P., Fléjou, J. F., Monges, G., Bedossa, P., Bioulac-Sage, P., Capron, F., Schmilz, A., Olschwang, S., and Thomas, G. Concerted nonsyntenic allelic losses in hyperploid hepatocellular carcinoma as determined by a high-resolution allelotype. Cancer Res., 57: 1986-1990, 1997.
35. Mertens, F., Johansson, B., and Mitelman, F. Chromosomal imbalance maps of malignant solid tumors: a cytogenetic survey of 3185 neoplasms. Cancer Res., 57: 2765-2780, 1997.